Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management of infections.

R J Whitley, W M Crist

    Pediatric Annals
    |June 1, 1983
    PubMed
    Summary

    Advances in managing bacterial and viral infections in immunocompromised patients have improved survival. Early antimicrobial therapy and new antivirals are key, with future needs including better antibacterial agents and viral vaccines.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impact of human coronavirus infections on paediatric patients at a tertiary paediatric hospital: a retrospective study of the prepandemic era.

    The Journal of hospital infection·2023
    Same author

    Foreword.

    Perspectives in medical virology·2020
    Same author

    Assessment of oncolytic HSV efficacy following increased entry-receptor expression in malignant peripheral nerve sheath tumor cell lines.

    Gene therapy·2014
    Same author

    Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2013
    Same author

    Treatment of herpes simplex virus infections in pediatric patients: current status and future needs.

    Clinical pharmacology and therapeutics·2010
    Same author

    Engineered herpes simplex virus expressing bacterial cytosine deaminase for experimental therapy of brain tumors.

    Cancer gene therapy·2006

    Area of Science:

    • Infectious Diseases
    • Immunology
    • Pharmacology

    Background:

    • Immunocompromised hosts are highly susceptible to severe bacterial and viral infections.
    • Management of these infections has seen significant progress over the past decade.
    • Early intervention is critical for improving outcomes in this vulnerable population.

    Purpose of the Study:

    • To review recent advances in the management of bacterial and viral infections in immunocompromised individuals.
    • To highlight the impact of early antimicrobial therapy and antiviral development.
    • To identify future directions for preventing and treating infections in immunosuppressed patients.

    Main Methods:

    • Review of recent clinical studies and therapeutic developments.
    • Analysis of the impact of empiric antibacterial therapy on mortality and morbidity.
    • Evaluation of antiviral therapies for herpes virus infections.

    Main Results:

    • Empiric antibacterial therapy has significantly reduced mortality and morbidity from bacterial infections.
    • Antiviral development has improved survival rates for children with chickenpox and herpes simplex virus infections.
    • Current strategies demonstrate the effectiveness of prompt treatment.

    Conclusions:

    • Continued progress in managing infections in immunocompromised hosts is evident.
    • Future research should focus on developing novel antibacterial agents.
    • Prevention strategies, including live attenuated viral vaccines, are crucial for future viral infection control.

    Related Experiment Videos